Gene · 7706
Papers2,924
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 2,924
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Targeting the TRIM25-AGO2-miR-148b-5p-ABCC1 axis overcomes chemoresistance in non-small cell lung cancer. | Cell Death Dis | 2026 | 42062253 | PubTator, text mining | PubMed |
| The long isoform of ZAP coordinates multiple enzymes to mediate complete decay of target transcripts. | Cell Rep | 2026 | 42054207 | PubTator, text mining | PubMed |
| ISGylation is disrupted by UBA7 gene variants identified in individuals with neurodevelopmental disorder phenotypes. | iScience | 2026 | 42023152 | PubTator, text mining | PubMed |
| FeiyanHeji multifunctionally inhibits influenza virus via PA protein degradation and RIG-I signaling pathway potentiation. | Chin Med | 2026 | 42021383 | PubTator, text mining | PubMed |
| TRIM25 promotes glioblastoma progression by stabilizing HIF-1α expression in normoxia through K11/K29 polyubiquitination. | Cell Death Dis | 2026 | 42020378 | PubTator, text mining | PubMed |
| TRIM25-mediated ferroptosis resistance is closely associated with poor prognosis in hepatocellular carcinoma. | Front Immunol | 2026 | 41993211 | PubTator, text mining | PubMed |
| Long noncoding RNA AC007637.1 inhibits tumorigenesis by regulating the Trim25/PCNA axis in colorectal cancer. | J Adv Res | 2026 | 41951040 | PubTator, text mining | PubMed |
| TRIM25 promotes antiviral innate immune response by stabilizing IRF7 and its nuclear translocation. | mBio | 2026 | 41919938 | PubTator, text mining | PubMed |
| The Flavivirus NS3 Protein: Its Multifaceted Roles and Therapeutic Potential. | J Med Virol | 2026 | 41910366 | PubTator, text mining | PubMed |
| Porcine hemagglutinating encephalomyelitis virus nucleocapsid protein targets RIG-I and IRF3 to evade IFN immunity. | J Virol | 2026 | 41910148 | PubTator, text mining | PubMed |
| Immunopathogenesis of Severe Fever with Thrombocytopenia Syndrome: Core Driving Role of Cytokine Storm. | Curr Issues Mol Biol | 2026 | 41899415 | PubTator, text mining | PubMed |
| USP10 deubiquitinase: Physiological function, diseases and therapeutic target (Review). | Int J Mol Med | 2026 | 41891958 | PubTator, text mining | PubMed |
| Juvenile idiopathic arthritis-associated RIG-I S144F variant inhibits type I interferon signaling by blocking TRIM25-mediated ubiquitination. | Genes Dis | 2026 | 41884719 | PubTator, text mining | PubMed |
| Reactive oxygen species (ROS) in cancer: from mechanism to therapeutic implications. | Signal Transduct Target Ther | 2026 | 41881983 | PubTator, text mining | PubMed |
| Malic enzyme 2 suppresses PINK1-Parkin-mediated mitophagy by stabilizing ATAD3A via competitive interaction with TRIM25. | Cell Death Dis | 2026 | 41876455 | PubTator, text mining | PubMed |
| m5C RNA methylation is dysregulated by oncogenic herpesviruses via c-Myc signaling to counteract host antiviral factors. | Nucleic Acids Res | 2026 | 41873763 | PubTator, text mining | PubMed |
| Inhibition of coronaviral exoribonuclease activity by TRIM-mediated SUMOylation. | Proc Natl Acad Sci U S A | 2026 | 41871251 | PubTator, text mining | PubMed |
| Innate immune recognition and evasion strategies of hepatitis B virus: from DNA to RNA and viral proteins. | Front Immunol | 2026 | 41869349 | PubTator, text mining | PubMed |
| Cancer-associated SF3B1 mutation suppresses DNA repair by disrupting the organization of nuclear actin network. | Cell Death Dis | 2026 | 41864997 | PubTator, text mining | PubMed |
| USP20 governs tyrosine kinase inhibitors resistance through ferroptosis evasion by targeting GPX4 in cancers. | Redox Biol | 2026 | 41844497 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7706/papers?page=3